350
5th Asia-Australia Congress on Controversies in Ophthalmology
Asia-Australia COPHy 2019
5th Asia-Australia Congress on Controversies in Ophthalmology
Asia-Australia COPHy 2019
Comtecmed
53 Rothschild Boulevard
IL - 61000 Tel Aviv
Tel.: +972 (3) 566 6166
Fax: +972 (3) 566 6177
-
Basisinformation
Datum21.02.2019, 19:00 - 23.02.2019, 18:00KongressShanghai ShiSpracheEnglischGebühren ab330.00 EURVeranstalterComtecmed
OrganisatorComtecmed
53 Rothschild Boulevard
IL - 61000 Tel Aviv
Tel.: +972 (3) 566 6166
Fax: +972 (3) 566 6177 -
VERANSTALTUNGSORT
Venue Pudong Shangri-La 33 Fucheng Rd, LuJiaZui, Pudong Xinqu, Shanghai Shi, China, 200120
Pudong Shangri-La 33 Fucheng Rd
200120 Shanghai Shi, CN -
Programm
RETINA FRIDAY, FEBRUARY 22, 2019
HALL A 08:30-10:00
OPENING SESSION | Big Controversies in Ophthalmology in 2019
Chairs:
Neil Bressler, USA 08:30-09:00
Debate I: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment
08:30-08:40
Yes: Susan Bressler, USA
08:40-08:50 No 08:50-09:00 Discussion 09:00-09:30
Debate II: Neuro-protection in glaucoma: A viable pursuit
09:00-09:10
Yes: Christopher Leung, Hong Kong
09:10-09:20 No 09:20-09:30 Discussion 09:30-10:00
Debate III: Atrophine should be used in children to prevent myopia
09:30-09:40
Yes: Tien Yin Wong, Singapore
09:40-09:50
No, not in all cases
09:50-10:00
Discussion 10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break 10:30-12:00
RETINA I | Choroidal Neovascular Age-related Macular Degeneration
Chairs:
Xiaoxin Li, China; Adrian Koh, Singapore 10:30-11:00
Debate I: Treat and extend regimens are superior to PRN regimens
10:30-10:40
Yes: Gemmy Cheung, Singapore
10:40-10:50 No: Susan Bressler, USA 10:50-11:00 Discussion 11:00-11:30
Debate II: Large submacular hemorrhages typically should be managed initially with surgery, not anti-VEGF injections
11:00-11:10
Yes: Yaiji Sakamoto, Japan
11:10-11:20 No: Paisan Ruamviboonsuk, Thailand 11:20-11:30 Discussion 11:30-12:00
Debate III: New agents or delivery devices represents a clinically relevant advance in managing neovascular AMD
11:30-11:40
Yes: Jun Kong, China
11:40-11:50
No: Sherman Valero, Philippines
11:50-12:00
Discussion 12:00-12:15 Visit to Exhibits & Technical Break 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break 13:45-15:15 RETINA II | Diabetic Macular Edema
Chairs: Xiaofeng Lin, China; Susan Bressler, USA 13:45:14:15 Debate I: Consider alternative treatment regimens for patients with suboptimal vision responses after first 3 intravitreal anti-VEGF injections 13:45-13:55
Yes: Michaella Goldstein, Israel 13:55-14:05
No: Voraporn Chikitmongkol, Thailand 14:05-14:15
Discussion 14:15-14:45 Debate II: For persistent DME after 6 injections, add focal/grid laser 14:15-14:25 Yes: Jun Kong, China 14:25-14:35 No: Timothy Lai, Hong Kong 14:35-14:45 Discussion 14:45-15:15 Debate III: Artificial intelligence is ready to be used widely for DR Screening 14:45-14:55 Yes 14:55-15:05 No: Daniel Ting, Singapore 15:05-15:15 Discussion 15:15-16:45 RETINA III| Retinal Detachment and Vitrectomy Chairs: Joseph Moisseiev, Israel; Taiji Sakamoto, Japan 15:15-15:45 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy 15:15-15:25
Yes: Adrian Koh, Singapore 15:25-15:35
No: Taiji Sakamoto, Japan 15:35-15:45
Discussion 15:45-16:15 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye 15:45-15:55
Yes: Adiel Barak, Israel 15:55-16:05
No: Joseph Moisseiev, Israel 16:05-16:15
Discussion 16:15-16:45 Debate III: Attempt to treat focal vitreomacular traction with gas injection should be tried before considering vitrectomy 16:15-16:25 Yes: Shibo Tang, China 16:25-16:35 No: Adiel Barak, Israel 16:35-16:45 Discussion SATURDAY, FEBRUARY 23, 2019
HALL A 09:00-10:00
Vision Academy in Retina 2019
Chairs:
09:00-09:10 An introduction to Vision Academy 09:10-09:30
Debate I: A fellow eye to an eye with actively treated CMV would best be monitored by sophisticated home monitoring technology (PHP, Home OCT)
09:10-09:15
Yes
09:15-09:20 No 09:20-09:25 Presentation of viewpoint 09:25-09:30
Questions 09:30-09:50
Debate II: Futility of treatment: In some cases in which no improvement is anticipated treatment should be stopped
09:30-09:35
Yes
09:35-09:40 No 09:40-09:45
Presentation of viewpoint 09:45-09:50
Questions 09:50-10:00 Looking forward with the Vision Academy 10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break 10:30-12:00 RETINA IV | Polypoidal Choroidal Vasculopathy
Chairs: Adrian Koh, Singapore; Won Ki Lee, South Korea 10:30-11:00 Debate I: EVEREST 2 and PLANET results should be compared 10:30-10:40
Yes: Won Ki Lee, South Korea 10:40-10:50 No: Adrian Koh, Singapore 10:50-11:00
Discussion 11:00-11:30 Debate II: ICG Angiography is needed to manage most cases of PCV 11:00-11:10
Yes
11:10-11:20 No: Voroporn Chaikitmongkol, Thailand
11:20-11:30 Discussion
11:30-12:00 Debate III: OCT-Angiography is useful in management of PCV 11:30-11:40
Yes: Gemmy Cheung, Singapore
11:40-11:50
No: Timothy Lai, Hong Kong
11:50-12:00
Discussion 12:00-12:15 Visit to Exhibition & Lunch Box Pick Up 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break 13:45-15:15 RETINA V | Pathologic Myopia
Chairs: Hua Yan, China; Joseph Moisseiev, Israel 13:45:14:15 Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia 13:45-13:55
Yes 13:55-14:05
No 14:05-14:15
Discussion 14:15-14:45 Debate II: Macular hemorrhage without leakage on fluorescein or ICG angiography should be treated empirically with anti-VEGF therapy or PDT with verteporfin for possible choroidal neovascularization obscured by hemorrhage 14:15-14:25
Yes: Young Hee Yoon, South Korea 14:25-14:35
No: Shibo Tang, China 14:35-14:45
Discussion 14:45-15:15 Debate III: Myopic foveoschisis should be treated by vitrectomy 14:45-14:55
Yes: Joseph Moissieiv, Israel 14:55-15:05
No: Adiel Barak, Israel 15:05-15:15
Discussion 15:15-16:45 RETINA VI | Retinal Vein Occlusions
Chairs: Xiaoling Liang, China; Timothy Lai, Hong Kong 15:15-15:45 Debate I: Intravitreal steroids are a viable choice as first line therapy 15:15-15:25
Yes: Barry Kuppermann, USA 15:25-15:35
No: Gemmy Cheung, Singapore 15:35-15:45
Discussion 15:45-16:15 Debate II: SCORE 2 results: Choose aflibercept over bevacizumab for macular edema secondary to central retinal vein occlusion 15:45-15:55
Yes: Susan Bressler, USA 15:55-16:05
No: Young Hee Yoon, South Korea 16:05-16:15
Discussion 16:15-16:45 Debate III: Unilateral retinal vein occlusions in older individuals typically warrant work-up for systemic disease 16:15-16:25
Yes: Paisan Ruamviboonsuk, Thailand 16:25-16:35
No 16:35-16:45
Discussion 17:00-18:30 Think Tank: Controversies Across Ophthalmology
Chairs: Xiaxin Li, China; Tin Aung, Singapore; Paisan Ruamviboonsuk, Thailand 17:00-17:30 Debate I: Removal of cataract increases the risk of progression of macular degeneration 17:00-17:10
Yes: Barry Kuppermann, USA 17:10-17:20
No 17:20-17:30
Discussion 17:30-18:00 Debate II: Big data are the next big thing in ophthalmology 17:30-17:40
Yes: Daniel Ting, Singapore 17:40-17:50
No: Sherman Valero, Philippines 17:50-18:00
Discussion 18:00-18:30 Spirinolactone is effective as a treatment for CSR 18:00-18:10
Yes 18:10-18:20
No: Michaella Goldstein, Israel 18:20-18:30
Discussion GLAUCOMA
FRIDAY, FEBRUARY 22, 2019
HALL B 10:30-12:00 GLAUCOMA I | Screening and Monitoring Controversies
Chairs: Christopher Leung, Hong Kong 10:30-11:00 Debate I: MIGS is a passing fad 10:30-10:40
Yes
10:40-10:50
No: Christopher Leung, Hong Kong 10:50-11:00
Discussion 11:00-11:30 Debate II: Clear lens extraction is indicated for angle-closure glaucoma 11:00-11:10
Yes: Tin Aung, Singapore 11:10-11:20
No 11:20-11:30
Discussion 11:30-12:00 Debate III: Genetic profiling has a role in management of glaucoma 11:30-11:40
Yes 11:40-11:50
No 11:50-12:00
Discussion 12:00-12:15 Visit to Exhibition & Lunch Box Pick Up 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break SATURDAY, FEBRUARY 23, 2019
HALL B 13:45-15:15 GLAUCOMA II | Management: Present and Future
Chairs: Ningli Wang, China; Ryo Asaoka, Japan 13:45:14:15 Debate I: Sustained release glaucoma systems will replace eye drops 13:45-13:55
Yes: Tin Aung, Singapore 13:55-14:05
No 14:05-14:15
Discussion 14:15-14:45 Debate II: Optic disc photography is outdated when we have OCT 14:15-14:25
Yes 14:25-14:35
No: Ryo Asaoka, Japan 14:35-14:45
Discussion 14:45-15:15 Debate III: Neuroprotective therapy for glaucoma will be available in the next 5 years 14:45-14:55
Yes: Christopher Leung, Hong Kong 14:55-15:05
No: Ryo Asaoka, Japan 15:05-15:10
Discussion ANTERIOR SEGMENT FRIDAY, FEBRUARY 22, 2019
HALL B 13:45-15:15 ANTERIOR SEGMENT I | Cataract
Chairs: Ehud Assia, Israel 13:45:14:15 Debate I: High myopia is best corrected by clear lens extraction 13:45-13:55
Yes 13:55-14:05
No: Ehud Assia, Israel 14:05-14:15
Discussion 14:15-14:45 Debate II: Suture fixation is better than intraocular fixation of IOL 14:15-14:25
Yes 14:25-14:35
No: Shaowei Li, China 14:35-14:45
Discussion 14:45-15:15 Debate III: Presbyopic correction should be considered in all cataract operations 14:45-14:55
Yes 14:55-15:05
No: Danying Zheng, China 15:05-15:10
Discussion SATURDAY, FEBRUARY 23, 2019
HALL B 14:00-15:30 ANTERIOR SEGMENT II | Cornea
Chairs: 15:15-15:45 Debate I: Toric IOLs should be used only in eyes with corneal regular astigmatism 15:15-15:25
Yes 15:25-15:35
No: Ehud Assia, Israel 15:35-15:45
Discussion 15:45-16:15 Debate II: DMEK typically is better than DSAEK 15:45-15:55
Yes 15:55-16:05
No 16:05-16:15
Discussion 16:15-16:45 Debate III: Laser refractive surgery: Lasik typically should be chosen over SMILE for up to -12 diopters 16:15-16:25
Yes 16:25-16:35 No 16:35-16:45
Discussion NEURO-OPHTHALMOLOGY FRIDAY, FEBRUARY 22, 2019
HALL B
15:15-16:45 NEURO-OPHTHALMOLOGY I | Afferent
Chairs: Andrew Lee, USA 15:15-15:45
Debate I: There is treatment for traumatic optic neuropathy
15:15-15:25
Yes 15:25-15:35
No: Andrew Lee, USA 15:35-15:45
Discussion 15:45-16:15
Debate II: There is treatment for non-arteritic anterior ischemic optic neuropathy (NAION) 15:45-15:55
Yes: Andrew Lee, USA 15:55-16:05
No 16:05-16:15
Discussion 16:15-16:45
Case Presentations
Moderator: Andrew Lee, USA
Panelist: All Speakers
SATURDAY, FEBRUARY 23, 2019
HALL B
10:30-12:00
NEURO-OPHTHALMOLOGY II | Efferent
Chairs: Andrew Lee, USA 10:30-11:00
Debate I: All patients with acute 6th nerve palsy should be imaged
10:30-10:40
Yes 10:40-10:50
No: Andrew Lee, USA 10:50-11:00
Discussion 11:00-11:30
Debate II: All patients with third nerve palsies should be imaged
11:00-11:10
Yes
11:10-11:20
No: Andrew Lee, USA 11:20-11:30
Discussion 11:30-12:00
Case Presentations
Moderator: Andrew Lee, USA
Panelist
12:00-12:15 Visit to Exhibition & Lunch Box Pick Up 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break DeadlinesAbstract
31.12.2018Hinweis -
Gebühren
Fachärzte/-innenGebühren ab430,00 EURStudenten/-innenGebühren ab330,00 EURmedizinisches FachpersonalGebühren ab330,00 EUREARLY
REGISTRATION
Until Jan 10, 2019
Trainees*, Nurses: € 330,00
Trainees*, Nurses from surrounding countries**: € 230,00
LATE
REGISTRATION
Jan 11 – Feb 12, 2019
Trainees*, Nurses: € 400,00
Trainees*, Nurses from surroundi -
Buchung / Anmeldung
Registration required. For further information please contact the organizer.
-
Zertifizierung
Keine Zertifizierung beantragt
- Sponsoren